Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 116

1.

The emotional and psychological impact of multiple sclerosis relapses.

Kalb R.

J Neurol Sci. 2007 May 15;256 Suppl 1:S29-33. Epub 2007 Mar 9. Review.

PMID:
17350045
[PubMed - indexed for MEDLINE]
2.

The psychosocial effect of multiple sclerosis: the impact of relapses.

Halper J.

J Neurol Sci. 2007 May 15;256 Suppl 1:S34-8. Epub 2007 Mar 9. Review.

PMID:
17350047
[PubMed - indexed for MEDLINE]
3.

A systematic approach to analyse health-related quality of life in multiple sclerosis: the GEDMA study.

Morales-Gonzáles JM, Benito-León J, Rivera-Navarro J, Mitchell AJ; GEDMA Study Group.

Mult Scler. 2004 Feb;10(1):47-54.

PMID:
14760952
[PubMed - indexed for MEDLINE]
4.

Quality of life in 1000 patients with early relapsing-remitting multiple sclerosis.

Putzki N, Fischer J, Gottwald K, Reifschneider G, Ries S, Siever A, Hoffmann F, Käfferlein W, Kausch U, Liedtke M, Kirchmeier J, Gmünd S, Richter A, Schicklmaier P, Niemczyk G, Wernsdörfer C, Hartung HP; "Mensch im Mittelpunkt" Study Group.

Eur J Neurol. 2009 Jun;16(6):713-20.

PMID:
19475754
[PubMed - indexed for MEDLINE]
5.

Influence of anxiety and reported stressful life events on relapses in multiple sclerosis: a prospective study.

Potagas C, Mitsonis C, Watier L, Dellatolas G, Retziou A, Mitropoulos P, Sfagos C, Vassilopoulos D.

Mult Scler. 2008 Nov;14(9):1262-8. doi: 10.1177/1352458508095331. Epub 2008 Aug 28.

PMID:
18755825
[PubMed - indexed for MEDLINE]
6.

Disease-modifying agents in the Sonya Slifka Longitudinal Multiple Sclerosis Study.

Minden S, Hoaglin D, Jureidini S, Hadden L, Frankel D, Komatsuzaki Y, Outley J.

Mult Scler. 2008 Jun;14(5):640-55. doi: 10.1177/1352458507086463.

PMID:
18566028
[PubMed - indexed for MEDLINE]
7.

Longitudinal assessment of anxiety, depression, and fatigue in people with multiple sclerosis.

Brown RF, Valpiani EM, Tennant CC, Dunn SM, Sharrock M, Hodgkinson S, Pollard JD.

Psychol Psychother. 2009 Mar;82(Pt 1):41-56. doi: 10.1348/147608308X345614. Epub 2008 Aug 25.

PMID:
18727845
[PubMed - indexed for MEDLINE]
8.

Patient education program to enhance decision autonomy in multiple sclerosis relapse management: a randomized-controlled trial.

Köpke S, Kasper J, Mühlhauser I, Nübling M, Heesen C.

Mult Scler. 2009 Jan;15(1):96-104. doi: 10.1177/1352458508095921. Epub 2008 Oct 9.

PMID:
18845657
[PubMed - indexed for MEDLINE]
9.

Family caregiver quality of life in multiple sclerosis among Kuwaitis: a controlled study.

Alshubaili AF, Ohaeri JU, Awadalla AW, Mabrouk AA.

BMC Health Serv Res. 2008 Oct 7;8:206. doi: 10.1186/1472-6963-8-206.

PMID:
18840287
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Neurological disability, psychological distress, and health-related quality of life in MS patients within the first three years after diagnosis.

Kern S, Schrempf W, Schneider H, Schultheiss T, Reichmann H, Ziemssen T.

Mult Scler. 2009 Jun;15(6):752-8. doi: 10.1177/1352458509103300.

PMID:
19482864
[PubMed - indexed for MEDLINE]
11.

Relapses matter: the costs & consequences of multiple sclerosis relapses.

Coyle PK, Johnson KP.

J Neurol Sci. 2007 May 15;256 Suppl 1:S1-4. Epub 2007 Mar 9. Review. No abstract available.

PMID:
17350044
[PubMed - indexed for MEDLINE]
12.

Management of patients who have relapses in multiple sclerosis.

Williams G.

Br J Nurs. 2004 Sep 23-Oct 13;13(17):1012-6. Review.

PMID:
15549010
[PubMed - indexed for MEDLINE]
13.

Treatment adherence in multiple sclerosis: association with emotional status, personality, and cognition.

Bruce JM, Hancock LM, Arnett P, Lynch S.

J Behav Med. 2010 Jun;33(3):219-27. doi: 10.1007/s10865-010-9247-y. Epub 2010 Feb 3.

PMID:
20127401
[PubMed - indexed for MEDLINE]
14.

A comparison of mood and quality of life among people with progressive neurological illnesses and their caregivers.

McCabe MP, Firth L, O'Connor E.

J Clin Psychol Med Settings. 2009 Dec;16(4):355-62. doi: 10.1007/s10880-009-9168-5. Epub 2009 Jul 29.

PMID:
19639395
[PubMed - indexed for MEDLINE]
15.

Introduction: adherence to disease-modifying therapies--key to optimizing outcomes in relapsing multiple sclerosis.

Caon C, Saunders C, Smrtka J, Davis K, Davis A, Kay JM, Baxter N.

J Neurosci Nurs. 2010 Oct;42(5 Suppl):S1-4. No abstract available.

PMID:
21049827
[PubMed - indexed for MEDLINE]
16.

Effects of education level and employment status on HRQoL in early relapsing-remitting multiple sclerosis.

Patti F, Pozzilli C, Montanari E, Pappalardo A, Piazza L, Levi A, Onesti E, Pesci I; Italian Study Group On Quality Of Life In Ms.

Mult Scler. 2007 Jul;13(6):783-91. Epub 2007 Feb 16.

PMID:
17613607
[PubMed - indexed for MEDLINE]
17.

Coping and quality of life in one hundred and thirty five subjects with multiple sclerosis.

Montel SR, Bungener C.

Mult Scler. 2007 Apr;13(3):393-401. Epub 2007 Jan 29.

PMID:
17439909
[PubMed - indexed for MEDLINE]
18.

Control of multiple sclerosis relapses with immunomodulating agents.

Johnson KP.

J Neurol Sci. 2007 May 15;256 Suppl 1:S23-8. Epub 2007 Mar 12. Review.

PMID:
17350652
[PubMed - indexed for MEDLINE]
19.

Mitoxantrone as induction treatment in aggressive relapsing remitting multiple sclerosis: treatment response factors in a 5 year follow-up observational study of 100 consecutive patients.

Le Page E, Leray E, Taurin G, Coustans M, Chaperon J, Morrissey SP, Edan G.

J Neurol Neurosurg Psychiatry. 2008 Jan;79(1):52-6. Epub 2007 Sep 10.

PMID:
17846110
[PubMed - indexed for MEDLINE]
20.

The natural history of relapses in multiple sclerosis.

Vollmer T.

J Neurol Sci. 2007 May 15;256 Suppl 1:S5-13. Epub 2007 Mar 7. Review.

PMID:
17346747
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk